Cognitive-Behavioral Therapy vs Risperidone for Augmenting Serotonin Reuptake Inhibitors in Obsessive-Compulsive Disorder: A Randomized Clinical Trial

IMPORTANCE: Obsessive-compulsive disorder (OCD) is one of the world’s most disabling illnesses according to the World Health Organization. Serotonin reuptake inhibitors (SRIs) are the only medications approved by the Food and Drug Administration to treat OCD, but few patients achieve minimal symptom...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Simpson, Helen Blair, Foa, Edna B., Liebowitz, Michael R., Huppert, Jonathan D., Cahill, Shawn, Maher, Michael J., McLean, Carmen P., Bender, James, Marcus, Sue M., Williams, Monnica T., Weaver, Jamie, Vermes, Donna, Van Meter, Page E., Rodriguez, Carolyn I., Powers, Mark, Pinto, Anthony, Imms, Patricia, Hahn, Chang-Gyu, Campeas, Raphael
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2013
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3955365/
https://ncbi.nlm.nih.gov/pubmed/24026523
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamapsychiatry.2013.1932
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg